PainChek to secure FDA De Novo classification

PainChek to secure FDA De Novo classification

Formerly ePat Technologies (ASX: EPT), medical device company PainChek (ASX: PCK) is on course to secure De Novo classification from the Food and Drug Administration (FDA) in the US — a relatively new process for novel devices which have not previously been classified.

Read more..